SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-081824
Filing Date
2023-10-31
Accepted
2023-10-31 16:25:51
Documents
16
Period of Report
2023-10-30
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea187555-8k_inmune.htm   iXBRL 8-K 38577
2 PRESS RELEASE DATED OCTOBER 31, 2023 ea187555ex99-1_inmune.htm EX-99.1 20959
3 PRESS RELEASE DATED OCTOBER 30, 2023 ea187555ex99-2_inmune.htm EX-99.2 15374
7 GRAPHIC ex99-1_001.jpg GRAPHIC 1883
8 GRAPHIC ex99-2_001.jpg GRAPHIC 1883
  Complete submission text file 0001213900-23-081824.txt   269260

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inmb-20231030.xsd EX-101.SCH 3018
5 XBRL LABEL FILE inmb-20231030_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE inmb-20231030_pre.xml EX-101.PRE 22361
10 EXTRACTED XBRL INSTANCE DOCUMENT ea187555-8k_inmune_htm.xml XML 3436
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 231364865
SIC: 2836 Biological Products, (No Diagnostic Substances)